Novo Nordisk became Europe’s most valuable company

Novo Nordisk became Europe’s most valuable company after launching Wegovy in the UK. The firm is known for Ozempic, a diabetes drug. A stock jump of 2.47% raised its market value to US$428 billion. It briefly overtook LVMH, valued at US$419 billion. Wegovy launched in the UK recently in a limited manner. The drug is […]

Leave a Reply

Your email address will not be published. Required fields are marked *